Chapter 13 Phosphorylation of IRS Proteins. Yin-Yang Regulation of Insulin Signaling

Vitamins and Hormones

Volumn 80, Issue C, 2009, Pages 351-387

  Sun, Xiao Jian ^a   Liu, Feng ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE;

ANIMAL; CHINESE MEDICINE; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; YIN-YANG;

EID: 61349133020     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00613-4     Document Type: Review

References (232)

1. Aguirre V., Uchida T., Yenush L., Davis R., and White M.F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275 (2000) 9047-9054
2. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., and White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277 (2002) 1531-1537
3. Anai M., Funaki M., Ogihara T., Terasaki J., Inukai K., Katagiri H., Fukushima Y., Yazaki Y., Kikuchi M., Oka Y., and Asano T. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47 (1998) 13-23
4. Anai M., Ono H., Funaki M., Fukushima Y., Inukai K., Ogihara T., Sakoda H., Onishi Y., Yazaki Y., Kikuchi M., Oka Y., and Asano T. Different subcellular distribution and regulation of expression of insulin receptor substrate (IRS)-3 from those of IRS-1 and IRS-2. J. Biol. Chem. 273 (1998) 29686-29692
5. Andreozzi F., Laratta E., Procopio C., Hribal M.L., Sciacqua A., Perticone M., Miele C., Perticone F., and Sesti G. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol. Cell. Biol. 27 (2007) 2372-2383
6. Araki E., Sun X.J., Haag B.L., Zhang Y., Chuang L.M., Yang-Feng T., White M.F., and Kahn C.R. Human skeletal muscle insulin receptor substrate-1: Characterization of the cDNA, gene and chromosomal localization. Diabetes 42 (1993) 1041-1054
7. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag B., Johnson III R.S., and Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372 (1994) 186-190
8. Argaud D., Kirby T.L., Newgard C.B., and Lange A.J. Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate. J. Biol. Chem. 272 (1997) 12854-12861
9. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191-198
10. Baltensperger K., Kozma L.M., Cherniack A.D., Klarlund J.K., Chawla A., Banerjee U., and Czech M.P. Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science 260 (1993) 1950-1952
11. Barinaga M. New clues to how proteins link up to run the cell. Science 283 (1999) 1247-1249
12. Bjornholm M., Kawano Y., Lehtihet M., and Zierath J. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46 (1997) 524-527
13. Bouzakri K., Roques M., Gual P., Espinosa S., Guebre-Egziabher F., Riou J.P., Laville M., Le Marchand-Brustel Y., Tanti J.F., and Vidal H. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52 (2003) 1319-1325
14. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., and Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
15. Cai D., Dhe-Paganon S., Melendez P.A., Lee J., and Shoelson S.E. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J. Biol. Chem. 278 (2003) 25323-25330
16. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005) 183-190
17. Cao T.T., Deacon H.W., Reczek D., Bretscher A., and von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 401 (1999) 286-290
18. Carlson C.J., White M.F., and Rondinone C.M. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem. Biophys. Res. Commun. 316 (2004) 533-539
19. Carpenter C.L., Auger K.R., Duckworth B.C., Hou W.M., Schaffhausen B., and Cantley L.C. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol. Cell. Biol. 13 (1993) 1657-1665
20. Cengel K.A., Kason R.E., and Freund G.G. Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase. Biochem. J. 335 (1998) 397-404
21. Chan R.J., and Feng G.S. PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood 109 (2007) 862-867
22. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
23. Chen J., Sadowski H.B., Kohanski R.A., and Wang L.H. Stat5 is a physiological substrate of the insulin receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 2295-2300
24. Chen J., Wu A., Sun H., Drakas R., Garofalo C., Cascio S., Surmacz E., and Baserga R. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J. Biol. Chem. 280 (2005) 29912-29920
25. Clark S.F., Martin S., Carozzi A.J., Hill M.M., and James D.E. Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: Potential involvement of a membrane skeleton. J. Cell Biol. 140 (1998) 1211-1225
26. Clark S.F., Molero J.C., and James D.E. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance. J. Biol. Chem. 275 6 (2002) 3819-3826
27. Cong F., Yuan B., and Goff S.P. Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol. Cell. Biol. 19 (1999) 8314-8325
28. Craparo A., O'Neill T.J., and Gustafson T.A. Non-SH2 domains within the insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor 1 receptor. J. Biol. Chem. 270 (1995) 15639-15643
29. Craparo A., Freund R., and Gustafson T.A. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J. Biol. Chem. 272 (1997) 11663-11669
30. Craven S.E., and Bredt D.S. PDZ proteins organize synaptic signaling pathways. Cell 93 (1998) 495-498
31. Czech M.P. Molecular actions of insulin on glucose transport. [Review]. Annu. Rev. Nutr. 15 (1995) 441-471
32. Czech M.P., Richardson D.K., Becker S.G., Walters C.G., Gitomer W., and Heinrich J. Insulin response in skeletal muscle and fat cells of the genetically obese Zucker rat. Metabolism 27 (1978) 1967-1981
33. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268 (1993) 14553-14556
34. De Fea K., and Roth R.A. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 36 (1997) 12939-12947
35. Dhand R., Hara K., Hiles I., Bax B., Gout I., Panayotou G., Fry M.J., Yonezawa K., Kasuga M., and Waterfield M.D. PI 3-kinase: Structural and functional analysis of intersubunit interactions. EMBO J. 13 (1994) 511-521
36. Dhand R., Hiles I., Panayotou G., Roche S., Fry M.J., Gout I., Totty N.F., Truong O., Vicendo P., Yonezawa K., Kasuga M., Courtneidge S.A., et al. PI-3-kinase is a dual specificity enzyme-Autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13 (1994) 522-533
37. Dong X., Park S., Lin X., Copps K., Yi X., and White M.F. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J. Clin. Invest. 116 (2006) 101-114
38. Dummler B., and Hemmings B.A. Physiological roles of PKB/Akt isoforms in development and disease. Biochem. Soc. Trans. 35 (2007) 231-235
39. Durocher D., Henckel J., Fersht A.R., and Jackson S.P. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell 4 (1999) 387-394
40. Eck M.J., Dhe-Paganon S., Trub T., Nolte R.T., and Shoelson S.E. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85 (1996) 695-705
41. Eck M.J., Pluskey S., Trub T., Harrison S.C., and Shoelson S.E. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 379 (1996) 277-280
42. Egawa K., Sharma P.M., Nakashima N., Huang Y., Huver E., Boss G.R., and Olefsky J.M. Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J. Biol. Chem. 274 (1999) 14306-14314
43. Eldar-Finkelman H., and Krebs E.G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl. Acad. Sci. USA 94 (1997) 9660-9664
44. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
45. Evans J.L., Maddux B.A., and Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistances. Antioxid. Redox Signal. 7 (2005) 1040-1052
46. Fantin V.R., Lavan B.E., Wang Q., Jenkins N.A., Gilbert D.J., Copeland N.G., Keller S.R., and Lienhard G.E. Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 gene. Endocrinology 140 (1999) 1329-1337
47. Fantin V.R., Wang Q., Lienhard G.E., and Keller S.R. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 278 1 (2000) E127-E133
48. Fingar D.C., and Blenis J. Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
49. Fisher T.L., and White M.F. Signaling pathways: The benefits of good communication. Curr. Biol. 14 (2004) R1005-R1007
50. Freed E., Symons M., Macdonald S.G., McCormick F., and Ruggieri R. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265 (1994) 1713-1716
51. Freund G.G., Wittig J.G., and Mooney R.A. The PI3-kinase serine kinase phosphorylates its p85 subunit and IRS-1 in PI3-kinase/IRS-1 complexes. Biochem. Biophys. Res. Commun. 206 (1995) 272-278
52. Fridlyand L.E., and Philipson L.H. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8 (2006) 136-145
53. Friedman J.E., Ishizuka T., Shao J., Huston L., Highman T., and Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48 (1999) 1807-1814
54. Furukawa N., Ongusaha P., Jahng W.J., Araki K., Choi C.S., Kim H.J., Lee Y.H., Kaibuchi K., Kahn B.B., Masuzaki H., Kim J.K., Lee S.W., et al. Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab. 2 (2005) 119-129
55. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., and Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 277 (2002) 48115-48121
56. Garami A., Zwartkruis F.J., Nobukuni T., Joaquin M., Roccio M., Stocker H., Kozma S.C., Hafen E., Bos J.L., and Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11 (2003) 1457-1466
57. Gibson T.J., Hyvonen M., Musacchio A., and Saraste M. PH domain: The first anniversary. Trends Biochem. Sci. 19 (1994) 349-353
58. Giorgetti S., Ballotti R., Kowalski-Chauvel A., Tartare S., and Van Obberghen E. The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3′-kinase in vitro. J. Biol. Chem. 268 (1993) 7358-7364
59. Giraud J., Leshan R., Lee Y.H., and White M.F. Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J. Biol. Chem. 279 (2004) 3447-3454
60. Giraud J., Haas M., Feener E.P., Copps K.D., Dong X., Fidyk N., and White M.F. Phosphorylation of irs1 at ser-522 inhibits insulin signaling. Mol. Endocrinol. 21 9 (2007) 2294-2302
61. Greene M.W., Ruhoff M.S., Roth R.A., Kim J.A., Quon M.J., and Krause J.A. PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem. Biophys. Res. Commun. 349 (2006) 976-986
62. Gregor M.G., and Hotamisligil G.S. Adipocyte stress: The endoplasmic reticulum and metabolic disease. J. Lipid Res. 48 (2007) 1905-1914
63. Gual P., Gonzalez T., Gremeaux T., Barres R., Le Marchand-Brustel Y., and Tanti J.F. Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes. J. Biol. Chem. 278 (2003) 26550-26557
64. Gual P., Le Marchand-Brustel Y., and Tanti J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87 (2005) 99-109
65. Gustafson T.A., He W., Craparo A., Schaub C.D., and O'Neill T.J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15 (1995) 2500-2508
66. Harrington L.S., Findlay G.M., Gray A., Tolkacheva T., Wigfield S., Rebholz H., Barnett J., Leslie N.R., Cheng S., Shepherd P.R., Gout I., Downes C.P., et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166 (2004) 213-223
67. He W., O'Neill T.J., and Gustafson T.A. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains. J. Biol. Chem. 270 (1995) 23258-23262
68. He J., Usui I., Ishizuka K., Kanatani Y., Hiratani K., Iwata M., Bukhari A., Haruta T., Sasaoka T., and Kobayashi M. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol. Endocrinol. 20 (2006) 114-124
69. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
70. Holgado-Madruga M., Emlet D.R., Moscatello D.K., Godwin A.K., and Wong A.J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379 (1996) 560-563
71. Horike N., Takemori H., Katoh Y., Doi J., Min L., Asano T., Sun X.J., Yamamoto H., Kasayama S., Muraoka M., Nonaka Y., and Okamoto M. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J. Biol. Chem. 278 (2003) 18440-18447
72. Hosomi Y., Shii K., Ogawa W., Matsuba H., Yoshida M., Okada Y., Yokono K., Kasuga M., Baba S., and Roth R. Characterization of a 60-Kilodalton substrate of the insulin receptor kinase. J. Biol. Chem. 269 (1994) 11498-11502
73. Hotamisligil G.S. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 (2003) S53-S55
74. Hotamisligil G.S. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54 Suppl. 2 (2005) S73-S78
75. Hotamisligil G.S., Peraldi P., Budvari A., Ellis R.W., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271 (1996) 665-668
76. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
77. Ikezu T., Okamoto T., Yonezawa K., Tompkins R.G., and Martyn J.A.J. Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms [In Process Citation]. J. Biol. Chem. 272 (1997) 25289-25295
78. Inoue G., Cheatham B., Emkey R., and Kahn C.R. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (irs)-1 and irs-2 [In Process Citation]. J. Biol. Chem. 273 (1998) 11548-11555
79. Irie K., Gotoh Y., Yashar B.M., Errede B., Nishida E., and Matsumoto K. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science 265 (1994) 1716-1719
80. Itani S.I., Ruderman N.B., Schmieder F., and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51 (2002) 2005-2011
81. Jaeschke A., and Davis R.J. Metabolic stress signaling mediated by mixed-lineage kinases. Mol. Cell 27 (2007) 498-508
82. Jaeschke A., Czech M.P., and Davis R.J. An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes Dev. 18 (2004) 1976-1980
83. Jakobsen S.N., Hardie D.G., Morrice N., and Tornqvist H.E. AMPK phosphorylates IRS-1 on Ser789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276 (2001) 46912-46916
84. Jiang Z.Y., Lin Y.W., Clemont A., Feener E.P., Hein K.D., Igarashi M., Yamauchi T., White M.F., and King G.L. Characterization of selective resistance to insulin signaling in the vasculature of obese zucker (fa/fa) rats. J. Clin. Invest. 104 (1999) 447-457
85. Kaburagi Y., Momomura K., Yamamoto-Honda R., Tobe K., Tamori Y., Sakura H., Akanuma Y., Yazaki Y., and Kadowaki T. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J. Biol. Chem. 268 (1993) 16610-16622
86. Kaburagi Y., Yamamoto-Honda R., Tobe K., Ueki K., Yachi M., Akanuma Y., Stephens R.M., Kaplan D., Yazaki Y., and Kadowaki T. The role of the NPXY motif in the insulin receptor in tyrosine phosphorylation of insulin receptor substrate-1 and Shc. Endocrinology 136 (1995) 3437-3443
87. Kaneto H., Nakatani Y., Miyatsuka T., Kawamori D., Matsuoka T.A., Matsuhisa M., Kajimoto Y., Ichijo H., Yamasaki Y., and Hori M. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med. 10 (2004) 1128-1132
88. Kanety H., Feinstein R., Papa M.Z., Hemi R., and Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J. Biol. Chem. 270 (1995) 23780-23784
89. Kasuga M., Hedo J.A., Yamada K.M., and Kahn C.R. The structure of the insulin receptor and its subunits: Evidence for multiple non-reduced forms and a 210K possible proreceptor. J. Biol. Chem. 257 (1982) 10392-10399
90. Kido Y., Burks D.J., Withers D., Bruning J.C., Kahn C.R., White M.F., and Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105 (2000) 199-205
91. Kim B., Leventhal P.S., White M.F., and Feldman E.L. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells [In Process Citation]. Endocrinology 139 (1998) 4881-4889
92. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., Shoelson S.E., and Shulman G.I. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108 (2001) 437-446
93. Kim J.K., Fillmore J.J., Sunshine M.J., Albrecht B., Higashimori T., Kim D.W., Liu Z.X., Soos T.J., Cline G.W., O'Brien W.R., Littman D.R., and Shulman G.I. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114 (2004) 823-827
94. Kim J.A., Yeh D.C., Ver M., Li Y., Carranza A., Conrads T.P., Veenstra T.D., Harrington M.A., and Quon M.J. Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: Cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance. J. Biol. Chem. 280 (2005) 23173-23183
95. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., Nakamichi I., Kikuchi A., and Nakayama K. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 18 (1999) 2401-2410
96. Klover P.J., Zimmers T.A., Koniaris L.G., and Mooney R.A. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52 (2003) 2784-2789
97. Klover P.J., Clementi A.H., and Mooney R.A. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146 (2005) 3417-3427
98. Koch C.A., Anderson D.J., Moran M.F., Ellis C.A., and Pawson T. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252 (1991) 668-674
99. Kosaki A., Yamada K., Suga J., Otaka A., and Kuzuya H. 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes [In Process Citation]. J. Biol. Chem. 273 (1998) 940-944
100. Kublaoui B., Lee J., and Pilch P.F. Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J. Biol. Chem. 270 (1995) 59-65
101. Kubota N., Tobe K., Terauchi Y., Eto K., Yamauchi T., Suzuki R., Tsubamoto Y., Komeda K., Nakano R., Miki H., Satoh S., Sekihara H., et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 (2000) 1880-1889
102. Kubota N., Terauchi Y., Tobe K., Yano W., Suzuki R., Ueki K., Takamoto I., Satoh H., Maki T., Kubota T., Moroi M., Okada-Iwabu M., et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J. Clin. Invest. 114 (2004) 917-927
103. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., and Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 (1999) 329-339
104. Kulkarni R.N., Winnay J.N., Daniels M., Bruning J.C., Flier S.N., Hanahan D., and Kahn C.R. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J. Clin. Invest. 104 (1999) R69-R75
105. Lassak A., Del V.L., Peruzzi F., Wang J.Y., Enam S., Croul S., Khalili K., and Reiss K. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J. Biol. Chem. 277 (2002) 17231-17238
106. Lavan B.E., Fantin V.R., Chang E.T., Lane W.S., Keller S.R., and Lienhard G.E. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family [In Process Citation]. J. Biol. Chem. 272 (1997) 21403-21407
107. Lavan B.E., Lane W.S., and Lienhard G.E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272 (1997) 11439-11443
108. Le Marchand-Brustel Y., Gual P., Gremeaux T., Gonzalez T., Barres R., and Tanti J.F. Fatty acid-induced insulin resistance: Role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem. Soc. Trans. 31 (2003) 1152-1156
109. Lee C.H., Li W., Nishimura R., Zhou M., Batzer A.G., Myers M.G., White M.F., Schlessinger J., and Skolnik E.Y. Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. Proc. Natl. Acad. Sci. USA 90 (1993) 11713-11717
110. Lee A.V., Gooch J.L., Oesterreich S., Guler R.L., and Yee D. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3′-kinase inhibition. Mol. Cell. Biol. 20 (2000) 1489-1496
111. Li J., DeFea K., and Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 274 (1999) 9351-9356
112. Li Y., Soos T.J., Li X., Wu J., Degennaro M., Sun X., Littman D.R., Birnbaum M.J., and Polakiewicz R.D. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J. Biol. Chem. 279 (2004) 45304-45307
113. Liberman Z., and Eldar-Finkelman H. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J. Biol. Chem. 280 (2005) 4422-4428
114. Lin X., Taguchi A., Park S., Kushner J.A., Li F., Li Y., and White M.F. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J. Clin. Invest. 114 (2004) 908-916
115. Liu S.C., Wang Q., Lienhard G.E., and Keller S.R. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J. Biol. Chem. 274 (1999) 18093-18099
116. Liu Y.F., Herschkovitz A., Boura-Halfon S., Ronen D., Paz K., LeRoith D., and Zick Y. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol. Cell. Biol. 24 (2004) 9668-9681
117. Lu P.J., Zhou X.Z., Shen M., and Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283 (1999) 1325-1328
118. Luo M., Reyna S., Wang L., Yi Z., Carroll C., Dong L.Q., Langlais P., Weintraub S.T., and Mandarino L.J. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: Regulatory role of serine 1223. Endocrinology 146 (2005) 4410-4416
119. Luttrell L.M., Hawes B.E., Touhara K., van Biesen T., Kock W.J., and Lefkowitz R.J. Effect of cellular expression of pleckstrin homology domains on Gi-coupled receptor signaling. J. Biol. Chem. 270 (1995) 12984-12989
120. Lyle A.N., and Griendling K.K. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 21 (2006) 269-280
121. Macias M.J., Musacchio A., Ponstingl H., Nilges M., Saraste M., and Oschkinat H. Structure of the pleckstrin homology domain from beta-spectrin. Nature 369 (1994) 675-677
122. Michael M.D., Kulkarni R.N., Postic C., Previs S.F., Shulman G.I., Magnuson M.A., and Kahn C.R. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6 (2000) 87-97
123. Miralpeix M., Sun X.J., Backer J.M., Myers M.G., Araki E., and White M.F. Insulin stimulates tyrosine phosphorylation of multiple high molecular weight substrates in FAO hepatoma cells. Biochemistry 31 (1992) 9031-9039
124. Moeschel K., Beck A., Weigert C., Lammers R., Kalbacher H., Voelter W., Schleicher E.D., Haring H.U., and Lehmann R. Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. J. Biol. Chem. 279 (2004) 25157-25163
125. Moodie S.A., Alleman-Sposeto J., and Gustafson T.A. Identification of the APS protein as a novel insulin receptor substrate [In Process Citation]. J. Biol. Chem. 274 (1999) 11186-11193
126. Morrison D. 14-3-3: Modulators of signaling proteins? [comment]. Science 266 (1994) 56-57
127. Musacchio A., Gibson T., Rice P., Thompson J., and Saraste M. The PH domain: A common piece in the structural patchwork of signalling proteins. Trends Biochem. Sci. 18 (1993) 343
128. Muslin A.J., Tanner J.W., Allen P.M., and Shaw A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84 (1996) 889-897
129. Myers Jr. M.G., Wang L.M., Sun X.J., Zhang Y., Yenush L., Schlessinger J., Pierce J.H., and White M.F. Role of IRS-1-GRB-2 complexes in insulin signaling. Mol. Cell. Biol. 14 (1994) 3577-3587
130. Myers M.G., Mendez R., Shi P., Pierce J.H., Rhoads R., and White M.F. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J. Biol. Chem. 273 (1998) 26908-26914
131. Nakajima K., Yamauchi K., Shigematsu S., Ikeo S., Komatsu M., Aizawa T., and Hashizume K. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J. Biol. Chem. 275 (2000) 20880-20886
132. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15 (1997) 351-369
133. Nakatani Y., Kaneto H., Kawamori D., Hatazaki M., Miyatsuka T., Matsuoka T.A., Kajimoto Y., Matsuhisa M., Yamasaki Y., and Hori M. Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem. 279 (2004) 45803-45809
134. Nawaratne R., Gray A., Jorgensen C.H., Downes C.P., Siddle K., and Sethi J.K. Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: Role of serine 24 phosphorylation. Mol. Endocrinol. 20 (2006) 1838-1852
135. O'Neill T.J., Craparo A., and Gustafson T.A. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14 (1994) 6433-6442
136. Ogihara T., Isobe T., Ichimura T., Taoka M., Funaki M., Sakoda H., Onishi Y., Inukai K., Anai M., Fukushima Y., Kikuchi M., Yazaki Y., Oka Y., and Asano T. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain [In Process Citation]. J. Biol. Chem. 272 (1997) 25267-25274
137. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Gorgun C., Glimcher L.H., and Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
138. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., and Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006) 1137-1140
139. Ozes O.N., Akca H., Mayo L.D., Gustin J.A., Maehama T., Dixon J.E., and Donner D.B. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 98 (2001) 4640-4645
140. Patti M.E., and Kahn B.B. Nutrient sensor links obesity with diabetes risk. Nat. Med. 10 (2004) 1049-1050
141. Pawson T. Protein modules and signalling networks. Nature 373 (1995) 573-580
142. Pawson T., and Gish G.D. SH2 and SH3 domains: From structure to function. Cell 71 (1992) 359-362
143. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., and Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 29911-29918
144. Pitcher J.A., Touhara K., Payne E.S., and Lefkowitz R.J. Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G-beta/gamma subunits and lipid. J. Biol. Chem. 270 (1995) 11707-11710
145. Pluskey S., Wandless T.J., Walsh C.T., and Shoelson S.E. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J. Biol. Chem. 270 (1995) 2897-2900
146. Plutzky J., Neel B.G., and Rosenberg R.D. Isolation of a src homology 2-containing tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 89 (1992) 1123-1127
147. Previs S.F., Withers D.J., Ren J.M., White M.F., and Shulman G.I. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275 (2000) 38990-38994
148. Prisco M., Santini F., Baffa R., Liu M., Drakas R., Wu A., and Baserga R. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J. Biol. Chem. 277 (2002) 32078-32085
149. Qiao L.Y., Goldberg J.L., Russell J.C., and Sun X.J. Identification of enhanced serine kinase activity in insulin resistance. J. Biol. Chem. 274 (1999) 10625-10632
150. Qiao L.Y., Zhande R., Jetton T.L., Zhou G., and Sun X.J. In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J. Biol. Chem. 277 (2002) 26530-26539
151. Razzini G., Ingrosso A., Brancaccio A., Sciacchitano S., Esposito D.L., and Falasca M. Different subcellular localization and phosphoinositides binding of insulin receptor substrate protein pleckstrin homology domains. Mol. Endocrinol. 14 6 (2001) 823-836
152. Ribon V., and Saltiel A.R. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem. J. 324 Pt. 3 (1997) 839-845
153. Rondinone C.M., Wang L.M., Lonnroth P., Wesslau C., Pierce J.H., and Smith U. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 94 (1997) 4171-4175
154. Rordorf-Nikolic T., Van Horn D.J., Chen D., White M.F., and Backer J.M. Regulation of phosphatidylinositol 3-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85 kDa regulatory subunit. J. Biol. Chem. 270 (1995) 3662-3666
155. Rosen O.M. After insulin binds. Science 237 (1987) 1452-1458
156. Rothenberg P.L., Lane W.S., Karasik A., Backer J.M., White M., and Kahn C.R. Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J. Biol. Chem. 266 (1991) 8302-8311
157. Rotter V., Nagaev I., and Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278 (2003) 45777-45784
158. Rui L., Aguirre V., Kim J.K., Shulman G.I., Lee A., Corbould A., Dunaif A., and White M.F. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 107 2 (2001) 181-189
159. Rui L., Fisher T.L., Thomas J., and White M.F. Regulation of insulin/IGF-1 signaling by proteasome-mediated degradation of IRS-2. J. Biol. Chem. 276 (2001) 40362-40367
160. Sampson S.R., and Cooper D.R. Specific protein kinase C isoforms as transducers and modulators of insulin signaling. Mol. Genet. Metab. 89 (2006) 32-47
161. Samuel V.T., Liu Z.X., Wang A., Beddow S.A., Geisler J.G., Kahn M., Zhang X.M., Monia B.P., Bhanot S., and Shulman G.I. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117 (2007) 739-745
162. Sasaoka T., Rose D.W., Jhun B.H., Saltiel A.R., Draznin B., and Olefsky J.M. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J. Biol. Chem. 269 (1994) 13689-13694
163. Savage D.B., Petersen K.F., and Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87 (2007) 507-520
164. Sawka-Verhelle D., Tartare-Deckert S., White M.F., and Van Obberghen E. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J. Biol. Chem. 271 (1996) 5980-5983
165. Sawka-Verhelle D., Baron V., Mothe I., Filloux C., White M.F., and Van Obberghen E. Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor. J. Biol. Chem. 272 (1997) 16414-16420
166. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann. N.Y. Acad. Sci. 967 (2002) 146-157
167. Senn J.J., Klover P.J., Nowak I.A., and Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 (2002) 3391-3399
168. Shah O.J., and Hunter T. Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis. Mol. Cell. Biol. 26 (2006) 6425-6434
169. Shimizu K., Kuroda S., Yamamori B., Matsuda S., Kaibuchi K., Yamauchi T., Isobe T., Irie K., Matsumoto K., and Takai Y. Synergistic activation by Ras and 14-3-3 protein of a mitogen-activated protein kinase kinase kinase named Ras-dependent extracellular signal-regulated kinase kinase stimulator. J. Biol. Chem. 269 (1994) 22917-22920
170. Shirane M., Hatakeyama S., Hattori K., and Nakayama K. Common pathway for the ubiquitination of IkappaBalpha, IkappaBbeta, and IkappaBepsilon mediated by the F-box protein FWD1. J. Biol. Chem. 274 (1999) 28169-28174
171. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 116 (2006) 1793-1801
172. Shoelson S.E., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 (2007) 2169-2180
173. Simpson L., Li J., Liaw D., Hennessy I., Oliner J., Christians F., and Parsons R. PTEN expression causes feedback upregulation of insulin receptor substrate 2. Mol. Cell. Biol. 21 (2001) 3947-3958
174. Skolnik E.Y., Batzer A.G., Li N., Lee C.H., Lowenstein E.J., Mohammadi M., Margolis B., and Schlessinger J. The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science 260 (1993) 1953-1955
175. Skowyra D., Craig K.L., Tyers M., Elledge S.J., and Harper J.W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91 (1997) 209-219
176. Smith L.K., Bradshaw M., Croall D.E., and Garner C.W. The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro. Biochem. Biophys. Res. Commun. 196 (1993) 767-772
177. Smith-Hall J., Pons S., Patti M.E., Burks D.J., Yenush L., Sun X.J., Kahn C.R., and White M.F. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 36 (1997) 8304-8310
178. Solinas G., Naugler W., Galimi F., Lee M.S., and Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. USA 103 (2006) 16454-16459
179. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G.D., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Birge R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., and Cantley J.C. SH2 domains recognize specific phosphopeptide sequences. Cell 72 (1993) 767-778
180. Spencer E., Jiang J., and Chen Z.J. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev. 13 (1999) 284-294
181. Staubs P.A., Reichart D.R., Saltiel A.R., Milarski K.L., Maegawa H., Berhanu P., Olefsky J.M., and Seely B.L. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, syp, and GAP. J. Biol. Chem. 269 (1994) 27186-27192
182. Stratford S., Hoehn K.L., Liu F., and Summers S.A. Regulation of insulin action by ceramide: Dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J. Biol. Chem. 279 (2004) 36608-36615
183. Sugimoto S., Lechleider R.J., Shoelson S.E., Neel B.G., and Walsh C.T. Expression, purification and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J. Biol. Chem. 269 (1994) 13614-13622
184. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45 (2006) 42-72
185. Summers S.A., and Nelson D.H. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54 (2005) 591-602
186. Sun X.J., Rothenberg P.L., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., and White M.F. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352 (1991) 73-77
187. Sun X.J., Miralpeix M., Myers M.G., Glasheen E.M., Backer J.M., Kahn C.R., and White M.F. The expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem. 267 (1992) 22662-22672
188. Sun X.J., Crimmins D.L., Myers M.G., Miralpeix M., and White M.F. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13 (1993) 7418-7428
189. Sun X.J., Wang L.M., Zhang Y., Yenush L., Myers M.G., Glasheen E., Lane W.S., Pierce J.H., and White M.F. Role of IRS-2 in insulin and cytokine signalling. Nature 377 (1995) 173-177
190. Sun X.J., Pons S., Asano T., Myers M.G., Glasheen E.M., White M.F., and Glasheen E. The fyn tyrosine kinase binds IRS-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271 (1996) 10583-10587
191. Sun X.J., Pons S., Wang L.-M., Zhang Y., Yenush L., Burks D., Myers M.G., Glasheen E.M., Copeland N.G., Jenkins N.A., Pierce J.H., and White M.F. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endocrinol. 11 (1997) 251-262
192. Sun X.J., Goldberg J.L., Qiao L.Y., and Mitchell J.J. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48 (1999) 1359-1364
193. Sun H., Tu X., Prisco M., Wu A., Casiburi I., and Baserga R. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol. Endocrinol. 17 (2003) 472-486
194. Suzuki R., Tobe K., Aoyama M., Inoue A., Sakamoto K., Yamauchi T., Kamon J., Kubota N., Terauchi Y., Yoshimatsu H., Matsuhisa M., Nagasaka S., Ogata H., Tokuyama K., Nagai R., and Kadowaki T. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J. Biol. Chem. 279 (2004) 25039-25049
195. Takeuchi H., Matsuda M., Yamamoto T., Kanematsu T., Kikkawa U., Yagisawa H., Watanabe Y., and Hirata M. PTB domain of insulin receptor substrate-1 binds inositol compounds. Biochem. J. 334 (1998) 211-218
196. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., Terauchi Y., Ueki K., Kaburagi Y., Satoh S., Sekihara H., Yoshioka S., Horikoshi H., Furuta Y., Ikawa Y., Kasuga M., Yazaki Y., and Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372 (1994) 182-186
197. Tanaka S., and Wands J.R. A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J. Clin. Invest. 98 (1996) 2100-2108
198. Tanasijevic M.J., Myers M.G., Thomas R.S., Crimmons D.L., White M.F., and Sacks D.B. Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II. J. Biol. Chem. 268 (1993) 18157-18166
199. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: Insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85-96
200. Tanti J.F., Gremeaux T., Van Obberghen E., and Le Marchand-Brustel Y. Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle. J. Biol. Chem. 266 (1991) 2099-2103
201. Tanti J.F., Gremeaux T., Van Obberghen E., and Le Marchand-Brustel Y. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem. J. 304 (1994) 17-21
202. Tanti J.F., Gremeaux T., Van Obberghen E., and Le Marchand-Brustel Y. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269 8 (1994) 6051-6057
203. Tartare-Deckert S., Murdaca J., Sawka-Verhelle D., Holt K.H., Pessin J.E., and Van Obberghen E. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF-I) receptor: Comparative study using the yeast two-hybrid system. Endocrinology 137 (1996) 1019-1024
204. Thirone A.C., Huang C., and Klip A. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol. Metab. 17 (2006) 72-78
205. Tremblay F., Brule S., Hee U.S., Li Y., Masuda K., Roden M., Sun X.J., Krebs M., Polakiewicz R.D., Thomas G., and Marette A. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 104 (2007) 14056-14061
206. Trojanek J., Croul S., Ho T., Wang J.Y., Darbinyan A., Nowicki M., Valle L.D., Skorski T., Khalili K., and Reiss K. T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J. Cell. Physiol. 206 (2006) 35-46
207. Tsiotra P.C., and Tsigos C. Stress, the endoplasmic reticulum, and insulin resistance. Ann. N.Y. Acad. Sci. 1083 (2006) 63-76
208. Tsuji Y., Kaburagi Y., Terauchi Y., Satoh S., Kubota N., Tamemoto H., Kraemer F.B., Sekihara H., Aizawa S., Akanuma Y., Tobe K., Kimura S., and Kadowaki T. Subcellular localization of insulin receptor substrate family proteins associated with phosphatidylinositol 3-kinase activity and alterations in lipolysis in primary mouse adipocytes from IRS-1 null mice. Diabetes 50 (2001) 1455-1463
209. Ullrich A., Bell J.R., Chen E.Y., Herrera R., Petruzzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.C., Tsubokawa M., Mason A., Seeburg P.H., Grunfeld C., Rosen O.M., and Ramachandran J. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313 (1985) 756-761
210. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
211. Valverde A.M., Burks D.J., Fabregat I., Fisher T.L., Carretero J., White M.F., and Benito M. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52 (2003) 2239-2248
212. Van Horn D.J., Myers M.G., and Backer J.M. Direct activation of the phosphatidylinositol 3′-kinase by the insulin receptor. J. Biochem. 269 1 (1994) 29-32
213. Virkamaki A., Ueki K., and Kahn C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103 (1999) 931-943
214. Wang L.M., Keegan A.D., Paul W.E., Heidaran M.A., Gutkind J.S., and Pierce J.H. IL-4 activates a distinct signal transduction cascade from IL-3 in factor dependent myeloid cells. EMBO J. 11 (1992) 4899-4908
215. Wang L.M., Keegan A.D., Li W., Lienhard G.E., Pacini S., Gutkind J.S., Myers M.G., Sun X.J., White M.F., Aaronson S.A., Paul W.E., and Pierce J.H. Common elements in interleukin 4 and insulin signaling pathways in factor dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90 (1993) 4032-4036
216. Weigert C., Hennige A.M., Brischmann T., Beck A., Moeschel K., Schauble M., Brodbeck K., Haring H.U., Schleicher E.D., and Lehmann R. The phosphorylation of Ser318 of insulin receptor substrate 1 is not per se inhibitory in skeletal muscle cells but is necessary to trigger the attenuation of the insulin-stimulated signal. J. Biol. Chem. 280 (2005) 37393-37399
217. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
218. Werner E.D., Lee J., Hansen L., Yuan M., and Shoelson S.E. Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J. Biol. Chem. 279 (2004) 35298-35305
219. White M.F. The IRS-signalling system in insulin and cytokine action. [Review]. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351 (1996) 181-189
220. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E413-E422
221. White M.F., Maron R., and Kahn C.R. Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. Nature 318 (1985) 183-186
222. White M.F., Livingston J.N., Backer J.M., Lauris V., Dull T.J., Ullrich A., and Kahn C.R. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54 (1988) 641-649
223. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner-Weir S., and White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
224. Wolf G., Trub T., Ottinger E., Groninga L., Lynch A., White M.F., Miyazaki M., Lee J., and Shoelson S.E. The PTB domains of IRS-1 and Shc have distinct but overlapping specificities. J. Biol. Chem. 270 (1995) 27407-27410
225. Wu A., Sciacca L., and Baserga R. Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts. J. Cell. Physiol. 195 (2003) 453-460
226. Xiang X., Yuan M., Song Y., Ruderman N., Wen R., and Luo Z. 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol. Endocrinol. 16 (2002) 552-562
227. Yaffe M.B., and Cantley L.C. Signal transduction. Grabbing phosphoproteins [News] [In Process Citation]. Nature 402 (1999) 30-31
228. Yamauchi T., Tobe K., Tamemoto H., Ueki K., Kaburagi Y., Yamamoto-Honda R., Takahashi Y., Yoshizawa F., Aizawa S., Akanuma Y., Sonenberg N., Yazaki Y., and Kadowaki T. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell. Biol. 16 (1996) 3074-3084
229. Yeh T.C., Ogawa W., Danielsen A.G., and Roth R.A. Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase. J. Biol. Chem. 271 (1996) 2921-2928
230. Yi Z., Luo M., Carroll C.A., Weintraub S.T., and Mandarino L.J. Identification of phosphorylation sites in insulin receptor substrate-1 by hypothesis-driven high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Chem. 77 (2005) 5693-5699
231. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., and Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236
232. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., and Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 (2001) 1673-1677